Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vic Hasselblad

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
The American Journal of Cardiology|May 15, 2003
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain unitsCarlos D Sánchez, L Kristin Newby, Vic Hasselblad, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Journal of General Internal Medicine|December 8, 2011
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new informationBenjamin J Powers, Remy R Coeytaux, Rowena J Dolor, et al.
American Heart Journal|July 2, 2005
Intensity and focus of heart failure disease management after hospital dischargeMonica R Shah, Carol M Flavell, Joanne R Weintraub, et al.
American Heart Journal|March 5, 2004
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trialsDavid E Kandzari, Vic Hasselblad, James E Tcheng, et al.
European Journal of Heart Failure|January 29, 2016
Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trialsYee Weng Wong, Robert J Mentz, G Michael Felker, et al.
Obstetrics and Gynecology|August 24, 2013
Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysisRachel Peragallo Urrutia, Remy R Coeytaux, Amanda J McBroom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysisPatricia G Moorman, Laura J Havrilesky, Jennifer M Gierisch, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
The American Journal of Cardiology|May 15, 2003
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain unitsCarlos D Sánchez, L Kristin Newby, Vic Hasselblad, et al.
Circulation|February 11, 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methodsKaren S Pieper, Anastasios A Tsiatis, Marie Davidian, et al.
The American Journal of Cardiology|March 17, 2004
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failureKaren E Joynt, Wendy A Gattis, Vic Hasselblad, et al.
Journal of the American College of Cardiology|June 1, 2002
Prognostic significance of elevated troponin I after percutaneous coronary interventionWarren J Cantor, L Kristin Newby, Robert H Christenson, et al.
Journal of General Internal Medicine|December 8, 2011
Updated report on comparative effectiveness of ACE inhibitors, ARBs, and direct renin inhibitors for patients with essential hypertension: much more data, little new informationBenjamin J Powers, Remy R Coeytaux, Rowena J Dolor, et al.
American Heart Journal|July 2, 2005
Intensity and focus of heart failure disease management after hospital dischargeMonica R Shah, Carol M Flavell, Joanne R Weintraub, et al.
American Heart Journal|March 5, 2004
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trialsDavid E Kandzari, Vic Hasselblad, James E Tcheng, et al.
European Journal of Heart Failure|January 29, 2016
Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trialsYee Weng Wong, Robert J Mentz, G Michael Felker, et al.
Obstetrics and Gynecology|August 24, 2013
Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysisRachel Peragallo Urrutia, Remy R Coeytaux, Amanda J McBroom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2013
Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysisPatricia G Moorman, Laura J Havrilesky, Jennifer M Gierisch, et al.
Pageof 13